India to Sudan: Vaccine Export Trade Route

The India to Sudan Vaccine corridor is one of India's established pharmaceutical export routes, with 186 shipments documented worth a combined $25.8M USD. The route is dominated by SERUM INSTITUTE OF INDIA PRIVATE LIMITED, which alone accounts for roughly 46% of all export value, reflecting the consolidated nature of India's vaccine manufacturing sector.

Across 29 active suppliers, the average shipment value stands at $138.8K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 80% of all shipments, consistent with vaccine's non-urgent bulk-order profile.

Shipment activity peaks during October–December, with an average transit time of 18 days port-to-port. The route has recorded an annual growth rate of 32.9%, placing it at rank #13 among India's top vaccine export destinations globally.

On the import side, key buyers of Indian vaccine in Sudan include XXICEXXSUPXXY DXXISIXX, UNICEF SUPPLY DIVISION, GENERAL DIRECTORATE OF GLOBAL HEALT and 44 others. XXICEXXSUPXXY DXXISIXX is the single largest importer with 2 shipments valued at $5.7M USD.

India's vaccine exports to Sudan are driven primarily by a handful of large-scale manufacturers. SERUM INSTITUTE OF INDIA PRIVATE LIMITED with 14 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 29 active exporters signals a competitive but concentrated market — buyers in Sudan benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — SERUM INSTITUTE OF INDIA PRIVATE LIMITED, PANACEA BIOTEC LIMITED, BIOLOGICAL E LIMITED — together account for 65% of total trade value on this route. The average shipment value of $138.8K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as easy five tt vaccine dtwp-hepb-hib penta and s359349 mr vaccine measles and rubella, suggesting that buyers in Sudan tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, XXICEXXSUPXXY DXXISIXX is the largest importer with 2 shipments worth $5.7M USD — representing 22% of all vaccine imports from India on this route. A total of 47 buyers are active on this corridor.